Degussa Aktiengesellschaft

Evonik Operations Gmbh

Evonik Degussa Gmbh

Degussa - Huls Ag

Degussa Gmbh

Michael Schwarm

Karlheinz Drauz

Guenter Knaup

Milan Latinovic

Bodo Speckmann

Maria-Regina Kula

Andreas Bommarius

Matthias Kottenhahn

Stefan Pelzer

Günter Knaup

Ines Ochrombel

G&uuml;nter Knaup

Thomas Gottstein

Wilfried Jahn

Ursula Stelkes-Ritter

Klaudia Wyzgol

Walter Pfefferle

Christoph Weckbecker

Kai Rossen

Dieter Seebach

Martin Schilling

Gunter Knaup

Hermann Lotter

Andrew Timothy Boam

Oliver May

Robert J Turner

Stefan Buchholz

Michael Kraft

Dieter Most

Mario Gomez

Joerg Lotz

Velichka Yordanova Koleva

Stefan Retzow

Yuri Bouwhuis

Oliver Werz

Maria Ines Fontes Rocha

Ian Fotheringham

Thomas Berngruber

Jörg Lotz

Jessica Kleinbolting

Jorg Lotz

The invention discloses preparations for use in enhancing formation of short-chain fatty acids (SCFAs) in a subject for treating or preventing a disease or disorder comprising at least one omega-3 fatty acid salt having an organic counter ion selected from lysine, arginine, ornithine, choline and mixtures of the same, wherein the omega-3 fatty acid is selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and a colon-specific delivery system.

Preparation for use in enhancing formation of short-chain fatty acids (SCFAs)

A synbiotic preparation may include at least one probiotic strain and at least one amino acid or derivative thereof selected from glutamine, glutamic acid or salts thereof, conjugated glutamine, or oligopeptides of 2-10 amino acid units in length, wherein the amino acid units may be natural amino acids, and at least one amino acid unit being a glutamine or glutamic acid unit.

Synbiotic compositions

Preparations may include at least one extract of gum resins fromspecies and at least one omega-3 fatty acid salt selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Surprisingly, such combinations of extracts of gum resins fromspecies and polyunsaturated fatty acid salt can cause a marked and unexpected increase in the biosynthesis of specialized pro-resolving mediators (SPM) in a synergistic manner, proposing benefit for resolution of inflammatory conditions.

Preparation comprising omega-3 fatty acid salts and extracts of gum resins fromspecies

The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salt(s), a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.

Tablets with high active ingredient content of omega-3 fatty acid amino acid salts

A solid product composition includes at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid. The solid product composition is formed by (i) providing a starting composition containing at least one polyunsaturated omega-3 fatty acid component; (ii) providing a lysine composition; and (iii) admixing an aqueous, an aqueous-alcoholic or an alcoholic solution of starting composition and lysine composition, and subjecting resulting admixture to spray drying conditions subsequently, thus forming the solid product composition containing at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid.

Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids

The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salts, a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.

The present invention relates to a method for preparing a composition comprising one or more omega-3 fatty acid salt(s), the composition obtainable or obtained by this method, and also the use of this composition for the preparation of foodstuffs, food supplements or pharmaceutical products.

Method for preparing a composition comprising omega-3 fatty acid salts and amines

A process for increasing the stability of a composition containing a polyunsaturated omega-3 fatty acid against oxidation proceeds by (i) providing a starting composition containing at least one polyunsaturated omega-3 fatty acid component; (ii) providing a lysine composition; (iii) admixing an aqueous, an aqueous-alcoholic or an alcoholic solution of starting composition and lysine composition, and subjecting resulting admixture to spray drying conditions subsequently, thus forming a solid product composition containing at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid; the product composition exhibiting a solvent content SC selected from the following: SC&#x3c;5 wt %, SC&#x3c;3 wt %, SC&#x3c;1 wt %, or SC&#x3c;0.5 wt %.

The present disclosure relates generally to a process for manufacturing products enriched in the content of at least one vitamin E component, preferably tocotrienol, using solvent extraction and membrane filtration.

Method for producing vitamin E-enriched, especially tocotrienol-enriched, compositions from natural oils

mutants which can be used for the synthesis of D-amino acids, and to such a process. The mutants are distinguished by deficiencies in particular enzymes which break down D-amino acids and include those which produce D-amino acids via the carbamoylase/hydantoinase route.

Mutants for the preparation of D-amino acids

The present invention is aimed at a process for the preparation of enantiomerically enriched compounds of general formula (I). These are obtained by classical resolution of the corresponding acid using a chiral amino base in organic solvents. 

Resolution of p-hydroxyphenyl-2-alkoxypropionic acids

Process for the preparation of 3-amino-2-oxo-pyrrolidines, novel intermediates and their use

A plant peptide amidase from the flavedo of oranges is known; this can be obtained only in small quantities and is seasonal. The proposed new enzymes are microbial peptide amidases which can be obtained from micro-organisms recovered from soil samples in a &ldquo;double screening&rdquo; and grown. These microbial peptide amidases are particularly useful for (a) the production of peptides and N-terminal-protected amino acids, (b) racemate splitting of N-protected amino acid amides, (c) obtaining non-proteinogenous D-amino acids, and (d) obtaining new N,-protected D-amino acid amides.

Process for obtaining microorganisms containing peptide amidase, microorganisms obtained therewith, peptide amidases contained in them and use thereof

The present invention relates to a process for the preparation of &ggr;-lactams of the general formula I

Peptide amidase from xanthomonas

Growing community of inventors

Alzenau, Germany

Michael Schwarm